Two former Theranos directors said they didn’t follow up on public allegations that the blood-testing firm was relying on standard technology rather than its much-hyped proprietary device for most.. Wall Street Journal
On April 18, 2017, a federal district court in California allowed indirect purchasers of stock in Theranos, a privately held company, to proceed with their lawsuit asserting securities violations Mondaq
Partner Management Fund LP will drop two lawsuits related to the startup’s fumbling of blood tests, Theranos officials said Monday in a statement. The settlement clears the way for Theranos to push.. SFGate Also reported by •bizjournals
Theranos has been having an awful time of it lately, mostly of its own making, with several lawsuits in place, including ones from Walgreens and hedge-fund Partner Fund Management (PFM). The company.. engadget Also reported by •TUAW
*Welcome to Finance Insider, Business Insider's summary of the top stories of the past 24 hours.*
US lawmakers are considering a bill to overhaul financial regulation in the US and unravel several.. Business Insider
Theranos has settled its lawsuits with a hedge fund that invested $96.1 million in the company.
Partner Fund Management originally sued Theranos in October 2016, alleging the company had "engaged.. Business Insider
Theranos settled a lawsuit alleging the company and its founder, Elizabeth Holmes, defrauded a San Francisco hedge fund into making a $96.1 million investment through “a series of lies.” Wall Street Journal
*From the Slope of Hope:* Earlier this week, my son asked me a sincere question: "How come *Marissa Mayer* got $200 million by screwing up Yahoo?"
It was a good question, and one I had trouble.. Zero Hedge
Authored by Mike Krieger via Liberty Blitzkrieg blog,
Last week, I wrote a post titled, *What Can an Overhyped Silicon Valley Juice Company Tell Us About the U.S. Economy*. Here’s how I ended the.. Zero Hedge
Theranos misled its directors and funders and used a shell company to "secretly" buy commercial lab equipment, according to a lawsuit filed by a former investor. The Wall Street Journal reported those.. bizjournals
Things just got a lot worse for Theranos, the beleaguered blood-testing company that's seen its share of bad press and class-action lawsuits. The latest complaint is mostly based on testimony from 22.. engadget Also reported by •TUAW
An investor said in newly unsealed court filings that Theranos used a shell company to buy commercial-lab equipment, then pretended it was using its own technology in demonstrations for prospective.. Wall Street Journal